Rotavirus live vaccine (Tetravalent, FRhL-2 cells, Brovovax)

轮状病毒活疫苗（四价，武汉博沃生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRotavirus live vaccine (Tetravalent, FRhL-2 cells, Brovovax)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsDiarrhea

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesWuhan Bravovax Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuhan Bravovax Co Ltd

Inactive CompaniesN/A

Active IndicationsDiarrhea

Inactive IndicationsN/A

Other Information

ATC CodeN/A